|  | Totala | Perceived risk | OR | 95 % CI | |
---|---|---|---|---|---|---|
Characteristics |  |  | Low (n = 116) | High (n = 29) |  |  |
 |  | n(%) | n(%) | n(%) |  |  |
Age (years) | <30 | 9 (6.29) | 5 (4.35) | 4 (14.29) | 1.00 | Â |
 | 30–39 | 36 (25.17) | 28 (24.35) | 8 (28.57) | 0.41 | 0.093, 1.83 |
 | 40–49 | 57 (39.86) | 47 (40.87) | 10 (35.71) | 0.38 | 0.093, 1.58 |
 | 50–59 | 32 (22.38) | 28 (24.35) | 4 (14.29) | 0.21 | 0.041, 1.11 |
 | 60+ | 9 (6.29) | 7 (6.09) | 2 (7.14) | 0.43 | 0.057, 3.22 |
Ethnicity | White | 119 (84.40) | 96 (85.71) | 23 (79.31) | 1.00 | Â |
 | Other | 22 (15.60) | 16 (14.29) | 6 (20.69) | 1.66 | 0.62, 4.47 |
Education | High School or less | 9 (6.21) | 8 (6.90) | 1 (3.45) | 1.00 | Â |
 | Some or completed undergraduate | 103 (71.03) | 81 (69.83) | 22 (75.86) | 1.42 | 0.29, 6.94 |
 | Some or completed graduate | 33 (22.76) | 27 (23.28) | 6 (20.69) | 1.11 | 0.19, 6.44 |
Personal Income | $19,999 or less | 35 (24.31) | 25 (21.55) | 10 (35.71) | 1.00 | Â |
 | $20,000–$59,999 | 60 (41.67) | 49 (42.24) | 11 (39.29) | 0.60 | 0.23, 1.54 |
 | $60,000–$99,999 | 31 (21.53) | 26 (22.41) | 5 (17.86) | 0.47 | 0.14, 1.55 |
 | $100,000 or more | 18 (12.50) | 16 (13.79) | 2 (7.14) | 0.31 | 0.060, 1.56 |
Lifetime number of HIV tests | Less than 5 | 27 (18.62) | 25 (21.55) | 2 (6.90) | 1.00 | Â |
5–9 | 44 (30.34) | 33 (28.45) | 11 (37.93) | 2.89 | 0.73, 11.44 | |
 | 10–19 | 41 (28.28) | 32 (27.59) | 9 (31.03) | 2.36 | 0.58, 9.62 |
 | 20–29 | 23 (15.86) | 17 (14.66) | 6 (20.69) | 3.06 | 0.67, 13.91 |
 | 30 or more | 10 (6.90) | 9 (7.76) | 1 (3.45) | 0.96 | 0.089, 10.48 |
Ever STI diagnosis | no | 40 (27.59) | 33 (28.45) | 7 (24.14) | 1.00 | Â |
 | yes | 105 (72.41) | 83 (71.50) | 22 (75.86) | 1.33 | 0.52, 3.38 |
Ever taken post-exposure prophylaxis (PEP) | No | 130 (90.28) | 105 (91.30) | 25 (86.21) | 1.00 | Â |
Yes | 14 (9.72) | 10 (8.70) | 4 (13.79) | 2.54 | 0.85, 7.66 | |
Used amyl nitrite (poppers) in previous 6Â months | No | 104 (72.73) | 91 (79.13) | 13 (46.43) | 1.00 | Â |
Yes | 39 (27.27) | 24 (20.87) | 15 (53.57) | 3.88 | 1.66, 9.02 | |
Used methamphetamines or crystal meth in previous 6Â months | No | 129 (90.21) | 106 (92.17) | 23 (82.14) | 1.00 | Â |
Yes | 14 (9.79) | 9 (7.83) | 5 (17.86) | 2.40 | 0.74, 7.78 | |
Marital status | Married/common law to male or female | 55 (38.19) | 45 (38.79) | 10 (35.71) | 1.00 | Â |
 | Divorced/separated/widowed from male or female | 22 (15.28) | 18 (15.52) | 4 (14.29) | 1.00 | 0.28, 3.60 |
 | Single, never married | 67 (46.53) | 53 (45.69) | 14 (50.00) | 1.31 | 0.54, 3.17 |
Component 1: Condom use during insertive or receptive anal sex with casual male partner or number of casual partners | Low | 49 (33.79) | 42 (36.21) | 7 (24.14) | 2.29 | 0.82, 6.39 |
Med | 49 (33.79) | 40 (34.48) | 9 (31.03) | 1.35 | 0.46, 3.97 | |
High | 47 (32.41) | 34 (29.31) | 13 (44.83) | 1.00 | Â | |
Component 2: Condom use during insertive or receptive anal sex with an HIV-positive regular male partner | Low | 48 (33.10) | 40 (34.48) | 8 (27.59) | 1.60 | 0.62, 4.12 |
Med | 31 (21.38) | 26 (22.41) | 5 (17.24) | 0.96 | 0.28, 3.62 | |
High | 66 (45.52) | 50 (43.10) | 16 (55.17) | 1.00 | Â | |
Component 3: Condom use during insertive or receptive anal sex with an HIV-unknown status regular male partner | Low | 49 (33.79) | 38 (32.76) | 11 (37.93) | 2.07 | 0.71, 6.01 |
Med | 72 (49.66) | 63 (54.31) | 9 (31.03) | 0.49 | 0.19, 1.30 | |
High | 24 (16.55) | 15 (12.93) | 9 (31.03) | 1.00 | Â | |
HIRI-MSM score (continuous) | median (IQR) | 10 (2–19) | 9 (2–16) | 18 (8–25) | 1.07 | 1.02, 1.11 |
HIRI-MSM score | 9 or less | 68 (46.90) | 60 (51.72) | 8 (27.59) | 1.00 | Â |
 | 10 or more | 77 (53.10) | 56 (48.28) | 21 (72.41) | 2.25 | 0.98, 5.18 |